Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search


Deal launches value-added dairy product into Japan

Media Release

Monday June 10th 2013: For Immediate Release

Distribution deal launches value-added dairy product into Japanese market

Hamilton, New Zealand - New Zealand-based dairy biotechnology company, Quantec Ltd, announced today that it has signed a distribution and supply agreement with a major Japanese specialty ingredients company, Kanematsu Chemicals Corporation.

Kanematsu will distribute Quantec’s patented complex of bioactive milk proteins, called IDP®, throughout Japan.

In a deal that is expected to extend over a number of years, the distribution agreement gives Quantec an expansion opportunity into a key Asian market and provides Kanematsu with access to a unique New Zealand dairy-based bioactive protein ingredient for inclusion into Japanese functional foods and human health products.

“Japanese consumers have always looked very favourably on New Zealand dairy products and we expect the agreement between Quantec and Kanematsu to further build on this customer perception of quality and innovation,” according to James Groenhart, Business Development Manager of Kanematsu New Zealand Ltd.

Founder and Managing Director of Quantec Ltd, Dr Rod Claycomb explained that, “IDP® is a unique ingredient naturally derived from fresh milk. It contains what we refer to as having ‘Triple-A’ activity - antibacterial, anti-inflammatory and antioxidant. For example, if used in an oral care product, IDP® targets and kills organisms responsible for bad odour while leaving healthy mouth organisms unharmed. It does so by being selective and targeting those characteristics of more harmful bacteria.

“We’ve been working with Kanematsu for over two years to test the Japanese market and prepare for product development and launch. We’re especially thankful to Peter Maxwell, Callaghan Innovation’s Business Growth Manager at Waikato Innovation Park in Hamilton, who recognised the opportunity for both Quantec and Kanematsu and made the initial introductions.”

Founded in 2007, Quantec is unlike many other dairy-based companies in New Zealand who are attempting to cash-in on the current trade of dairy commodities, like milk powder. Instead Quantec is focused on the discovery and commercialisation of high-value bioactive compounds from milk.

This agreement with Kanematsu of Japan comes on the heels of the signing of Quantec’s first major international distribution agreement, which is to supply its patented milk protein ingredient, IDP®, to China, through Auckland-based company, NZ New Paradise.


About Quantec Ltd
Based at the Waikato Innovation Park in Hamilton, New Zealand, Quantec is a company specialising in the discovery and commercialisation of high-value bioactives from natural products. Quantec discovered and patented its novel milk fraction, comprised of native immune defense proteins (IDP®), that has proven antimicrobial and anti-inflammatory properties.

About Kanematsu Chemicals Corporation
Kanematsu Corporation has had a long association with New Zealand through its subsidiary company, Kanematsu NZ Ltd, which has been active in the NZ primary food and agricultural export sector since 1937.

© Scoop Media

Business Headlines | Sci-Tech Headlines


$7.5 Billion Surplus: Government Accounts "Show Strong Economy"

“The surplus and low levels of debt show the economy is in good shape. This allows the Government to spend more on infrastructure and make record investments in health and education,” Grant Robertson says. More>>


New OIO Application Trumps Judicial Review: OceanaGold Cleared To Buy Land For Waihi Tailings Expansion

In a surprise turnaround, the government has given OceanaGold a greenlight to buy land to expand its Waihi mine after the application was previously turned down by Land Information Minister Eugenie Sage. More>>


Christchurch Rebuild: Fletcher Sued For $7.5m Over Justice Precinct

Fletcher Building is being sued for $7.5 million by utilities contractor Electrix, one of the subcontractors on the Christchurch Justice and Emergency Services Precinct. More>>

Three New Drugs: PHARMAC Signs Bundle Deal For More Cancer Medicines

420 New Zealanders with lung cancer, breast cancer, multiple sclerosis and respiratory disease will benefit each year from a bundle deal PHARMAC has finalised with a medicine supplier. More>>


"Levels Playing Field": Government Responds To Electricity Price Review

The changes announced today include: • Supporting new and independent retailers by requiring the big power companies to sell into the wholesale market at affordable rates. • Extending discount rates to all customers • A pilot scheme to help customers who have not switched power providers before to shop around for better deals... More>>